131 related articles for article (PubMed ID: 35210351)
1. Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol.
Branco-Silva M; Maesta I; Elias K; Berkowitz RS; Abbade JF; Horowitz NS
BMJ Open; 2022 Feb; 12(2):e059484. PubMed ID: 35210351
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
Jiang TY; Ren JJ; Zhang Y; Zhao Y; Feng XL
Medicine (Baltimore); 2021 Jun; 100(24):e26263. PubMed ID: 34128856
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
Luo F; Li L; Gao Q; Li YX
Medicine (Baltimore); 2021 Oct; 100(40):e27320. PubMed ID: 34622830
[TBL] [Abstract][Full Text] [Related]
4. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
6. Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis.
Madi JM; Paganella MP; Litvin IE; Viggiano M; Wendland EM; Elias KM; Horowitz NS; Braga A; Berkowitz RS
Am J Obstet Gynecol; 2022 May; 226(5):633-645.e8. PubMed ID: 34634262
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
[TBL] [Abstract][Full Text] [Related]
9. First line chemotherapy in low risk gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
[TBL] [Abstract][Full Text] [Related]
10. Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.
Hemida R; Vos EL; El-Deek B; Arafa M; Toson E; Burger CW; van Doorn HC
Obstet Gynecol; 2019 May; 133(5):1024-1031. PubMed ID: 30969220
[TBL] [Abstract][Full Text] [Related]
11. Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhang T; Guo Y; He X; Hou M; Wang L; An R; Gao L
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):636-644. PubMed ID: 38282348
[TBL] [Abstract][Full Text] [Related]
12. Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review.
John A; O'Callaghan M; Catterwell R; Selth L
BMJ Open; 2020 Mar; 10(3):e034612. PubMed ID: 32209629
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review.
Mansilla-Rodríguez ME; Romero-Jimenez MJ; Rigabert Sánchez-Junco A; Gutierrez-Cortizo EN; Sánchez-Ramos JL; Mata P; Pang J; Watts GF
BMJ Open; 2023 Mar; 13(3):e065551. PubMed ID: 36990476
[TBL] [Abstract][Full Text] [Related]
16. The association between human herpesvirus infections and stroke: a systematic review protocol.
Forbes HJ; Benjamin L; Breuer J; Brown MM; Langan SM; Minassian C; Smeeth L; Thomas SL; Warren-Gash C
BMJ Open; 2017 May; 7(5):e016427. PubMed ID: 28554940
[TBL] [Abstract][Full Text] [Related]
17. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
19. Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol.
Mendelsohn SC; Mulenga H; Mbandi SK; Darboe F; Shelton M; Scriba TJ; Hatherill M
BMJ Open; 2021 Aug; 11(8):e048623. PubMed ID: 34353800
[TBL] [Abstract][Full Text] [Related]
20. Diet quality during preconception or pregnancy and gestational weight gain: protocol for a systematic review and meta-analysis.
Yu Y; Hardy I; Sun W; Fergusson DA; Fraser W; Dubois L
BMJ Open; 2020 Feb; 10(2):e033130. PubMed ID: 32114465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
